SEC Company Response from ENvue Medical, Inc. (FEED) (CIK 0001326706) (FEED) — Jan 27, 2020
ENvue Medical, Inc. (FEED) (CIK 0001326706)
Date: Jan. 27, 2020 · CIK: 0001326706 · Accession: 0001213900-20-001938
AI Filing Summary & Sentiment
File numbers found in text: 333-236000
Show Raw Text
CORRESP
1
filename1.htm
NanoVibronix, Inc.
525 Executive Blvd.
Elmsford, NY 10523
January 27, 2020
By EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington, D.C. 20549
Attention: Chris Edwards
RE:
NanoVibronix, Inc.
Registration Statement on Form S-3
Filed January 22, 2020 (the “Registration Statement”)
Request for Acceleration
File No. 333-236000
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated
under the Securities Act of 1933, as amended, NanoVibronix, Inc. (the “Company”) hereby respectfully requests
acceleration of the effective date of the Registration Statement so that it may become effective at 5:00 p.m., Eastern Time, on
January 29, 2020, or as soon thereafter as practicable.
Should any member of the
staff of the U.S. Securities and Exchange Commission have any questions or comments with respect to this request, please contact
our counsel, Haynes and Boone, LLP, attention: Jayun Koo, Esq. at (212) 835-4823.
Very truly yours,
NanoVibronix, Inc.
By:
/s/ Brian Murphy
Brian Murphy
Chief Executive Officer
cc: Rick A. Werner, Esq., Haynes and Boone, LLP